Company Overview and News

Stock Market News For May 23, 2018

2018-05-23 zacks
Markets ended lower on Tuesday erasing early gains, after President Donald Trump said that he wasn’t satisfied with the progress of United States-China trade talks. Moreover, Trump also said that the highly awaited summit between the United States and North Korea might not happen at all.

US Automakers Offer Few ‘Cool’ Cheap Cars — for Now

2018-05-23 247wallst
Given the popularity of pickups and sport utility vehicles in the United States since the price of gasoline dropped sharply, along with the price of oil, a few years ago, it is little wonder that U.S. automakers are not well represented on Kelley Blue Book’s latest list of the 10 coolest cars under $20,000 for 2018.

General Motors Bridges The American Love For Pickup Trucks With $4 Gasoline

2018-05-21 seekingalpha
Gasoline prices are up 25% over the last year, but U.S. pickup truck sales are up 3% in 1Q 2018. What gives? And going forward?

Pickup Truck Fuel-Economy Battle Heats Up

2018-05-18 247wallst
Among full-size pickup trucks powered by gasoline, the Ford Motor Co. (NYSE: F) F-150 is the reigning champion, with U.S. Environmental Protection Agency (EPA) fuel-economy ratings of 20 miles per gallon in city driving, 26 mpg in highway driving and a combined rating of 22 mpg. General Motors Co. (NYSE: GM) and Fiat Chrysler Automobiles N.V. (NYSE: FCAU) are taking dead aim at those numbers with major improvements to their 2019 full-size pickups.

European Auto Sales Rise 10% in April; Ford Adds to Share

2018-05-17 247wallst
The European Automobile Manufacturers Association (ACEA) reported Thursday that new vehicle registrations in the European Union (EU) jumped 9.6% in April compared with new registrations in April of 2017. New registrations for the month totaled 1.31 million units.

Ford Restarts F-150 Production

2018-05-16 247wallst
After a fire took a supplier of parts for Ford’s (NYSE: F) F-150 offline and worried investors that the company’s No.1 selling vehicle by far would face falling inventories, the company announced that production is coming back online

Often-Mentioned 2008 Crisis Chiefly Forgotten

2018-05-16 seekingalpha
While reading an article about the economy and how things are different this time, it occurred to me that while we constantly refer to the often mentioned "2008 crisis," it has been chiefly forgotten and we have learned very little. By this, I'm pointing to the harsh reality and the details. The so-called Great Recession, blamed by many on a crisis in housing, is now so far in the rear-view that many people see it as merely a reset from which we have moved on.

Tracking Mohnish Pabrai's Portfolio - Q1 2018 Update

2018-05-15 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to Mohnish Pabrai’s 13F stock portfolio on a quarterly basis. It is based on Pabrai’s regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Mohnish Pabrai's Portfolio series for an idea on how his holdings have progressed over the years and our previous update highlighting the fund’s moves during Q4 2017.

AutoNation Gains From Store Openings, New-Vehicle Sales Hurt

2018-05-15 zacks
On May 14, we issued an updated research report on AutoNation, Inc. (AN - Free Report) . The company gains from its business-expansion plans through store openings and acquisitions. In the recently reported quarter, it acquired one collision center, opened one automotive auction and two AutoNation USA stores. The largest automotive retailer in the United States witnessed a year-over-year increase in revenues and adjusted earnings in first-quarter 2018.

Cummins (CMI) to Form JV With JAC Motors & Offer Engines

2018-05-15 zacks
Cummins Inc. (CMI - Free Report) announced that it will form a 50:50 joint venture (JV) with Anhui Jianghuai Automobile Co. Ltd. (JAC Motors). Additionally, Cummins acquired 50% equity of JAC-Navistar Diesel Engine Company from Navistar International Corporation (NAV - Free Report) . JAC Motors is an auto manufacturer with full-line independent brands in China. Per management, both the companies believe in similar values and focus on offering right power solutions to their customers.

The Bull Case For Cameco, Fiat Chrysler, & Yatra

2018-05-13 seekingalpha
While every other US auto manufacturer reported a decline in sales for April, Fiat Chrysler reported gains and smashed estimates.

Dodge Has a New Police Car

2018-05-11 247wallst
Several car companies have made police versions of their vehicles over the years. Among the things the upgraded vehicles have is fast engines. Fiat Chrysler Automobiles N.V.’s (NYSE: FCAU) Dodge division has taken a vehicle that is already fast and modified it for law enforcement.

The Don Meets With The Heads Of The 5 (Automotive) Families In The White House

2018-05-10 seekingalpha
The heads of the major automotive families head to Washington, D.C., where they will meet with The Don in order to settle on a new regulatory peace agreement.

How Many F-150 Sales Will Ford Lose to Silverado and Ram?

2018-05-10 247wallst
A fire at a Ford Motor Co. (NYSE: F) supplier has forced the company to shut down its F-150 and F-Series Super Duty production lines at three plants. This is very bad news for Ford. The company’s F-Series trucks accounted for more than a third of total vehicle unit sales in the first quarter of this year.

Ford Suspends Production Of Flagship F-150 Pick-Up, Gives Competition Daylight

2018-05-10 247wallst
The F-150 pick-up is Ford’s (NYSE: F) top selling vehicle and accounts for over a third of Ford’s unit sales in the U.S. It has also been the best selling vehicle in America by far for decades. Ford said it needs to suspend production at more than one facility because of supply chain problems. It is one of the rare chances competition will have to try to take market share in the full-sized pick-up segment

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

22h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

22h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: N31738102